Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qianwei Zhao

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Drug Issues|February 23, 2026
POLYDRUG USE PATTERNS AMONG MEXICAN AMERICAN WOMENAlice Cepeda, Jarron Saint Onge, Qianwei Zhao, et al.
Clinical Immunology (Orlando, Fla.)|February 5, 2026
Plasma anti-DLAT autoantibody as a novel diagnostic biomarker in breast cancerQianwei Zhao, Ludan Zhang, Peiqi Yu, et al.
Oncogene|June 22, 2021
Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCCFang Xu, Liya Jiang, Qianwei Zhao, et al.
International Journal of Molecular Sciences|November 14, 2023
Structural Insight into Polymerase Mechanism via a Chiral Center Generated with a Single Selenium AtomTong Qin, Bei Hu, Qianwei Zhao, et al.
Oncology Letters|January 7, 2021
Dysregulation of phosphoproteins in hepatocellular carcinoma revealed via quantitative analysis of the phosphoproteomeYixian Liu, Qianwei Zhao, Fang Xu, et al.
Journal of Zhejiang University. Science. B|September 16, 2022
BCAT1 promotes lung adenocarcinoma progression through enhanced mitochondrial function and NF-κB pathway activationMengdan Yu, Qianwei Zhao, Jinxia Li, et al.
Frontiers in Genetics|October 23, 2020
Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets DiscoveryQianwei Zhao, Zhendong Zhang, Jinxia Li, et al.
NPJ Precision Oncology|May 16, 2025
Hepatocellular carcinoma cells downregulate PGAM2 via SIRT2-mediated deacetylation modification to enhance aerobic glycolysisZexuan Wang, Yaoyu Guo, Kefei Hu, et al.
Hepatology Communications|March 4, 2024
Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasisZhendong Zhang, Qianwei Zhao, Zexuan Wang, et al.
Cancer Medicine|March 7, 2023
Sulfotransferase 1C2 promotes hepatocellular carcinoma progression by enhancing glycolysis and fatty acid metabolismLiya Jiang, Fang Xu, Chenglong Li, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Drug Issues|February 23, 2026
POLYDRUG USE PATTERNS AMONG MEXICAN AMERICAN WOMENAlice Cepeda, Jarron Saint Onge, Qianwei Zhao, et al.
Clinical Immunology (Orlando, Fla.)|February 5, 2026
Plasma anti-DLAT autoantibody as a novel diagnostic biomarker in breast cancerQianwei Zhao, Ludan Zhang, Peiqi Yu, et al.
Oncogene|June 22, 2021
Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCCFang Xu, Liya Jiang, Qianwei Zhao, et al.
International Journal of Molecular Sciences|November 14, 2023
Structural Insight into Polymerase Mechanism via a Chiral Center Generated with a Single Selenium AtomTong Qin, Bei Hu, Qianwei Zhao, et al.
Oncology Letters|January 7, 2021
Dysregulation of phosphoproteins in hepatocellular carcinoma revealed via quantitative analysis of the phosphoproteomeYixian Liu, Qianwei Zhao, Fang Xu, et al.
Journal of Zhejiang University. Science. B|September 16, 2022
BCAT1 promotes lung adenocarcinoma progression through enhanced mitochondrial function and NF-κB pathway activationMengdan Yu, Qianwei Zhao, Jinxia Li, et al.
Frontiers in Genetics|October 23, 2020
Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets DiscoveryQianwei Zhao, Zhendong Zhang, Jinxia Li, et al.
NPJ Precision Oncology|May 16, 2025
Hepatocellular carcinoma cells downregulate PGAM2 via SIRT2-mediated deacetylation modification to enhance aerobic glycolysisZexuan Wang, Yaoyu Guo, Kefei Hu, et al.
Hepatology Communications|March 4, 2024
Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasisZhendong Zhang, Qianwei Zhao, Zexuan Wang, et al.
Cancer Medicine|March 7, 2023
Sulfotransferase 1C2 promotes hepatocellular carcinoma progression by enhancing glycolysis and fatty acid metabolismLiya Jiang, Fang Xu, Chenglong Li, et al.
Pageof 3